Abstract:Hybridoma technology is widely used for monoclonal antibody (mAb) discovery, whereas the generation and identification of single hybridomas by the limiting dilution method (LDM) are tedious, inefficient, and time- and cost-consuming, especially for hapten molecules. Here, we describe a single transgenic hybridoma selection method (STHSM) that employs a transgenic Sp2/0 with an artificial and stable on-cell-surface anchor. The anchor was designed by combining the truncated variant transmembrane domain of EGFR with a biotin acceptor peptide AVI-tag, which was stably integrated into the genome of Sp2/0 via a piggyBac transposon. To ensure the subsequent precise selection of the hybridoma, the number of on-cell-surface anchors of the transfected Sp2/0 for fusion with immunized splenocytes was further normalized by flow cytometry at the single cell level. Then the single antigen-specific transgenic hybridomas were precisely identified and automatically selected using a CellenONE platform based on the fluorescence assay of the on-cell-surface anchor with the corresponding secreted antigen-specific mAb. The STHSM produced 579 single chloramphenicol (CAP)-specific transgenic hybridomas with a positive rate of 62.7% in 10 plates within 2 h by one-step selection, while only 12 single CAP-specific hybridomas with a positive rate of 6.3% in 40 plates required at least 32 days using the LDM with multiple subcloning steps. The best affinity of mAbs from the STHSM was more than 2-fold higher than that of those from the LDM, and this was mainly due to the preaffinity selection based on the on-cell-surface anchors and more interactions between the mAb and CAP. Then the mAbs from the STHSM and LDM were used to develop an immunoassay for CAP in spiked and natural biological samples. The method displayed satisfactory sensitivity, accuracy, and precision, demonstrating that the STHSM we developed is a versatile, practical, and efficient method for mAb discovery.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.2c02299.Additional experimental details, materials, methods, and results, including design of the on-cell-surface anchor, synthesis and characterization of CAP–protein conjugates, characterization of AVI-tag expression, animal immunization and antisera screening, hybridoma preparation by the LDM, preparation of the antibody variable region sequences, and homology modeling and molecular docking of Fvs-CAP (PDF)This article has not yet been cited by other publications.

An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery

Functional single-cell hybridoma screening using droplet-based microfluidics

High-throughput single-cell screening of viable hybridomas and patient-derived antibody-secreting cells using punchable microwells

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Online multimethod platform for comprehensive characterization of monoclonal antibodies in cell culture fluid from a single sample injection - Intact protein workflow

Droplet microfluidic technology for single-cell high-throughput screening

Miniaturized single-cell technologies for monoclonal antibody discovery

Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Application of Microfluidic Technology in Antibody Screening

Automated Reagent-Dispensing System for Microfluidic Cell Biology Assays.

A High-Throughput Hybrid Electromicrofluidic Platform for Organizing Single-Cell Protein Secretion Profiling Assays

A universal monoclonal antibody-aptamer conjugation strategy for selective non-invasive bioparticle isolation from blood on a regenerative microfluidic platform

PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology

Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics

Fluorescence-activated droplet sequencing (FAD-seq) directly provides sequences of screening hits in antibody discovery

Optimizing high throughput antibody purification by using continuous chromatography media

Single cell screening approaches for antibody discovery

Monoclonal Antibody Discovery Based on Precise Selection of Single Transgenic Hybridomas with an On-Cell-Surface and Antigen-Specific Anchor

Interfacing droplet microfluidics with antibody barcodes for multiplexed single-cell protein secretion profiling

Function-first discovery of high affinity monoclonal antibodies using Nanovial-based plasma B cell screening